Agios to Participate in December Investor Conference
November 30 2022 - 7:00AM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism pioneering therapies for rare diseases,
today announced that the company is scheduled to present at the
Bank of America 2022 Virtual Biotech SMID Cap Conference on
Wednesday, December 7, 2022, at 11:25 a.m. ET.
A live webcast of the presentations can be accessed
under "Events & Presentations" in the Investors section of the
company's website at www.agios.com. A replay of the webcast will be
archived on the Agios website for at least two weeks following the
presentation.
About AgiosAgios is a
biopharmaceutical company that is fueled by connections. The Agios
team cultivates strong bonds with patient communities, healthcare
professionals, partners and colleagues to discover, develop and
deliver therapies for rare diseases. In the U.S., Agios markets a
first-in-class pyruvate kinase (PK) activator for adults with PK
deficiency, the first disease-modifying therapy for this rare,
lifelong, debilitating hemolytic anemia. Building on the company's
leadership in the field of cellular metabolism, Agios is advancing
a robust clinical pipeline of investigational medicines with
programs in alpha- and beta-thalassemia, sickle cell disease,
pediatric PK deficiency and MDS-associated anemia. In addition to
its clinical pipeline, Agios has multiple investigational therapies
in preclinical development and an industry-leading research team
with unmatched expertise in cellular metabolism and genetics. For
more information, please visit the company’s website at
www.agios.com.
Investor and Media Contact:Jessica
Rennekamp, 857-209-3286Senior Director, Corporate
CommunicationsJessica.Rennekamp@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Apr 2024 to May 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From May 2023 to May 2024